ONCOLOGY INSTITUTE INC/THE (TOI:NASDAQ)
$4.71 0.1 (2.1692%)
Analysed ONCOLOGY INSTITUTE INC/THE (TOI:NASDAQ) News Sources
The Oncology Institute Announces First Quarter 2026 Earnings Release Date and Conference Call
27-04-2026
yahoo.com
Ensign Group (ENSG) Q1 Earnings Surpass Estimates
30-04-2026
yahoo.com
The Oncology Institute Reports First Quarter 2026 Financial Results
07-05-2026
yahoo.com
The Oncology Institute, Inc. (TOI) Reports Q1 Loss, Beats Revenue Estimates
07-05-2026
yahoo.com
The Oncology Institute, Inc. Q1 2026 Earnings Call Summary
08-05-2026
moby.co
Oncology Institute Q1 Earnings Call Highlights
09-05-2026
marketbeat.com
The Oncology Institute, Inc. (NASDAQ:TOI) Released Earnings Last Week And Analysts Lifted Their Price Target To US$7.00
11-05-2026
yahoo.com
The Oncology Institute to Participate in B. Riley Securities Institutional Investor Conference
13-05-2026
yahoo.com
Undervalued Small Caps With Insider Buying For May 2026
18-05-2026
yahoo.com
The Oncology Institute Chief Medical Officer to Speak on Value-Based Specialty Care at APG Spring Conference
26-05-2026
yahoo.com
What is the current price of ONCOLOGY INSTITUTE INC/THE (TOI:NASDAQ)?
The current price of ONCOLOGY INSTITUTE INC/THE (TOI:NASDAQ) is $4.71.
ONCOLOGY INSTITUTE INC/THE (TOI:NASDAQ) absolute price change since previous trading day?
The absolute price change of ONCOLOGY INSTITUTE INC/THE (TOI:NASDAQ) since the previous trading day is $0.1.
ONCOLOGY INSTITUTE INC/THE (TOI:NASDAQ) percentage price change since previous trading day?
The percentage price change of ONCOLOGY INSTITUTE INC/THE (TOI:NASDAQ) since the previous trading day is 2.1692%.
What is the most recent average sentiment score for ONCOLOGY INSTITUTE INC/THE (TOI:NASDAQ)?
The most recent average sentiment score for ONCOLOGY INSTITUTE INC/THE (TOI:NASDAQ) is 59 out of 100.
What is the most recent average sentiment for ONCOLOGY INSTITUTE INC/THE (TOI:NASDAQ)?
The most recent sentiment for ONCOLOGY INSTITUTE INC/THE (TOI:NASDAQ) is .
SEC-8K** Filing Available For ONCOLOGY INSTITUTE INC/THE (TOI:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.